TSTakehiro Sato

Takehiro Sato

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takehiro Sato has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Hironori Waki

    Department of Metabolism and Endocrinology Akita University Graduate School of Medicine Akita Japan

    3 shared publications
  • Sayaka Ando

    Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita 010-8543, Japan

    3 shared publications
  • Tatsunori Shimizu

    Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita 010-8543, Japan

    3 shared publications
  • Tsukasa Morii

    Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita 010-8543, Japan

    3 shared publications
  • Hiroki Fujita

    Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita 010-8543, Japan

    2 shared publications
  • K. Kurashima

    Advanced Materials Laboratory, National Institute for Materials Science, Namiki 1-1,#N#Tsukuba, Ibaraki 305-0044,#N#Japan

    2 shared publications

Latest Publications

  • Open Access

    Metreleptin improves glucose metabolism and hepatic steatosis in a patient with Werner syndrome and partial lipodystrophy: a case report with review of literature

    by Shogo Iwamura, Nagisa Nirei, Mari Matsuyama, Shinichiro Minami, Kana Sasaki, Sayaka Ando, Shunsuke Kato, Tatsunori Shimizu, Takehiro Sato, Tsukasa Morii, et al.

    Werner syndrome (WS) is a rare autosomal recessive progeroid disorder caused by mutations in the WRN gene and is characterized by distinctive physical features and metabolic complications, including insulin resistance, diabetes, hypertriglyceridemia, and hepatic steatosis. Although lipodystrophy is a recognized component of WS, clinical reports of metreleptin use in this setting remain very limited. We report the case of a 38-year-old woman with WS complicated by partial lipodystrophy, diabetes with suboptimal glycemic levels, hypertriglyceridemia and severe hepatic steatosis. She presented with distal limb lipoatrophy, a bird-like facial appearance, premature hair graying, and cataracts. Genetic testing identified two pathogenic WRN variants (c.1105C>T and c.3446del) resulting in premature protein termination, confirming the diagnosis. At baseline, hemoglobin A1c (HbA1c) was 8.6% despite insulin and oral hypoglycemic agents, and imaging demonstrated hepatomegaly with marked steatosis. Metreleptin therapy was initiated and titrated. Over 26 weeks, HbA1c improved to 7.4% and the visceral-to-subcutaneous fat ratio decreased, accompanied by reduction in liver transaminases, cholestatic enzymes, and imaging-based indices of hepatic steatosis, liver stiffness, and liver volume. To date, only three cases of WS treated with metreleptin, including ours, have been reported. While glycemic improvement is consistent with prior reports, our case additionally demonstrated improvements in hepatic steatosis across biochemical, and imaging parameters. These findings suggest that metreleptin may improve both glucose metabolism and hepatic steatosis in WS-associated lipodystrophy. Further accumulation of cases is essential to clarify its role in the management of WS.

  • Open Access

    Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study

    by Shunsuke Kato, Ayaka Kokita, Hana Akanuma, Shogo Iwamura, Yuya Takahashi, Ryota Kusumi, Sakiko Abe, Kana Sasaki, Hitomi Otomo, Sayaka Ando, et al.


  • Open Access

    Recurrent nocturnal hypoglycemic hemiplegia: a case report and review of the literature

    by Hanako Toyama, Kazuyuki Takahashi, Tatsunori Shimizu, Izumi Otaka, Sakiko Abe, Shunsuke Kato, Sayaka Ando, Takehiro Sato, Tsukasa Morii, Hiroki Fujita, et al.

    A 67-year-old man with type 1 diabetes, Cronkhite-Canada syndrome, and membranous nephropathy who received insulin therapy was admitted to our hospital with right hemiplegia and dysarthria. Brain magnetic resonance imaging revealed a lesion with a high diffusion-weighted imaging signal and low apparent diffusion coefficient signal in the posterior limb of the left internal capsule. He was hypoglycemic with a blood glucose level of 56 mg/dL (3.1 mmol/L). Following glucose administration, the patient’s symptoms resolved within several hours. The patient experienced similar transient hypoglycemic hemiplegia at midnight, three times within 10 days. In a literature review of 170 cases of hypoglycemic hemiplegia, 26 cases of recurrent hemiplegia were investigated. Recurrent hypoglycemic hemiplegia occurs more frequently on the right side than on the left side, and most recurrences occur within approximately a week, almost exclusively at midnight and in the early morning. We speculate that hypoglycemia-associated autonomic failure may be involved in the nocturnal recurrence of episodes. In our patient, depleted endogenous insulin secretion and lipodystrophy at the injection site, may have acted as additional factors, leading to severe hypoglycemia despite the absence of apparent autonomic neuropathy. Clinically, it is important to recognize hypoglycemia as a cause of hemiplegia to avoid unnecessary intervention and to maintain an appropriate blood glucose level at midnight and early in the morning to prevent recurrent hypoglycemic hemiplegia.


  • Co-produced carbon and boron nitride helical cones and the nucleation of curved BN sheets

    by L. Bourgeois, Y. Bando, K. Kurashima, T. Sato

    The structure of carbon (C) and boron nitride (BN) columnar particles produced alongside by heat-treating a turbostratic B—C—N compound was investigated by analytical transmission electron microscopy. The particles were shown to be helical cones with a well-defined apex, and a helical pitch equal to usually one and at most two layers. The cone apex angle distribution was found to be centred on different values for C and BN. These results strongly suggested that BN and C cones nucleated from different ring defects in the hexagonal networks: square-like ring defects in BN and pentagon-like ring defects in C. These observations were consistent with the supposition that the creation of non B—N bonds and hence odd-membered rings is avoided in BN. Such restriction in BN could also allow one to understand the observed morphological differences between C and BN cones, and in particular the relative difficulty for BN cone edges to join via curved sheets.